CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Other Operating Liabilities
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Other Operating Liabilities of $331.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2017-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2016-12-31 was -$286.00K, a 103.37% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2016-09-24 was $1.20M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2016-06-25 was -$221.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2016-03-26 was -$365.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for fiscal 2016 was $331.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for fiscal 2015 was -$3.66M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for fiscal 2014 was -$9.25M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating liabilities for fiscal 2013 was -$5.97M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | -$286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $917.00K derived: sum of 2 quarters · filed 2017-02-14 | $696.00K derived: sum of 3 quarters · filed 2017-02-14 | $331.00K 10-K · filed 2017-02-14 | ||||
| 2016-09-24 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $982.00K derived: sum of 2 quarters · filed 2016-11-02 | $617.00K 10-Q · filed 2016-11-02 | $9.11M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2016-06-25 | -$221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$586.00K 10-Q · filed 2016-08-03 | $7.90M derived: sum of 3 quarters · filed 2017-02-14 | $7.63M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2016-03-26 | -$365.00K 10-Q · filed 2016-05-04 | $8.12M derived: sum of 2 quarters · filed 2017-02-14 | $7.85M derived: sum of 3 quarters · filed 2017-02-14 | -$3.50M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-12-26 | $8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $8.21M derived: sum of 2 quarters · filed 2017-02-14 | -$3.13M derived: sum of 3 quarters · filed 2017-02-14 | -$3.66M 10-K · filed 2017-02-14 | ||||
| 2015-09-26 | -$274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$11.62M derived: sum of 2 quarters · filed 2016-11-02 | -$12.15M 10-Q · filed 2016-11-02 | -$18.56M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-27 | -$11.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$11.87M 10-Q · filed 2016-08-03 | -$18.28M derived: sum of 3 quarters · filed 2017-02-14 | -$18.66M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-28 | -$527.00K 10-Q · filed 2016-05-04 | -$6.94M derived: sum of 2 quarters · filed 2017-02-14 | -$7.31M derived: sum of 3 quarters · filed 2017-02-14 | -$7.12M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-27 | -$6.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$6.79M derived: sum of 2 quarters · filed 2017-02-14 | -$6.59M derived: sum of 3 quarters · filed 2017-02-14 | -$9.25M 10-K · filed 2017-02-14 | ||||
| 2014-09-27 | -$375.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$180.00K derived: sum of 2 quarters · filed 2015-11-04 | -$2.84M 10-Q · filed 2015-11-04 | -$3.48M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-28 | $195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$2.47M 10-Q · filed 2015-07-30 | -$3.11M derived: sum of 3 quarters · filed 2016-02-12 | -$6.05M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-29 | -$2.66M 10-Q · filed 2015-04-30 | -$3.31M derived: sum of 2 quarters · filed 2016-02-12 | -$6.25M derived: sum of 3 quarters · filed 2016-02-12 | -$7.48M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-28 | -$643.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$3.59M derived: sum of 2 quarters · filed 2016-02-12 | -$4.82M derived: sum of 3 quarters · filed 2016-02-12 | -$5.97M 10-K · filed 2016-02-12 | ||||
| 2013-09-28 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$4.17M derived: sum of 2 quarters · filed 2014-10-30 | -$5.33M 10-Q · filed 2014-10-30 | -$3.13M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-29 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$2.38M 10-Q · filed 2014-08-07 | -$189.00K derived: sum of 3 quarters · filed 2015-02-17 | -$1.30M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-30 | -$1.15M 10-Q · filed 2014-04-30 | $1.04M derived: sum of 2 quarters · filed 2015-02-17 | -$69.00K derived: sum of 3 quarters · filed 2015-02-17 | -$1.40M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2012-12-29 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $1.08M derived: sum of 2 quarters · filed 2015-02-17 | -$250.00K derived: sum of 3 quarters · filed 2015-02-17 | -$5.98M 10-K · filed 2015-02-17 | ||||
| 2012-09-29 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$2.44M derived: sum of 2 quarters · filed 2013-10-30 | -$8.18M 10-Q · filed 2013-10-30 | -$10.28M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | -$7.07M 10-Q · filed 2013-07-31 | -$9.17M derived: sum of 3 quarters · filed 2014-02-25 | -$10.84M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$5.73M 10-Q · filed 2013-05-08 | -$7.84M derived: sum of 2 quarters · filed 2014-02-25 | -$9.51M derived: sum of 3 quarters · filed 2014-02-25 | -$11.90M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$3.78M derived: sum of 2 quarters · filed 2014-02-25 | -$6.17M derived: sum of 3 quarters · filed 2014-02-25 | -$9.10M 10-K · filed 2014-02-25 | ||||
| 2011-09-24 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$4.06M derived: sum of 2 quarters · filed 2012-11-01 | -$6.99M 10-Q · filed 2012-11-01 | -$7.16M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-25 | -$2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$5.32M 10-Q · filed 2012-08-07 | -$5.49M derived: sum of 3 quarters · filed 2013-02-27 | -$9.97M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-26 | -$2.93M 10-Q · filed 2012-05-04 | -$1.01M 10-Q · filed 2011-05-04 | -$3.10M derived: sum of 2 quarters · filed 2013-02-27 | -$7.59M derived: sum of 3 quarters · filed 2013-02-27 | -$8.68M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-25 | -$167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$4.65M derived: sum of 2 quarters · filed 2013-02-27 | -$5.74M derived: sum of 3 quarters · filed 2013-02-27 | -$5.59M 10-K · filed 2013-02-27 | $7.49M 10-K · filed 2011-02-23 | |||
| 2010-09-25 | -$4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$5.58M derived: sum of 2 quarters · filed 2011-11-02 | -$5.43M 10-Q · filed 2011-11-02 | $4.12M 10-Q · filed 2010-11-04 | -$3.79M derived: sum of 4 quarters · filed 2012-02-27 | |||
| 2010-06-26 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$940.00K 10-Q · filed 2011-08-03 | $3.87M 10-Q · filed 2010-08-03 | $695.00K derived: sum of 3 quarters · filed 2012-02-27 | -$4.55M derived: sum of 4 quarters · filed 2012-02-27 | |||
| 2010-03-27 | $149.00K 10-Q · filed 2011-05-04 | $1.78M derived: sum of 2 quarters · filed 2012-02-27 | -$3.46M derived: sum of 3 quarters · filed 2012-02-27 | |||||
| 2009-12-26 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$3.61M derived: sum of 2 quarters · filed 2012-02-27 | -$4.61M 10-K · filed 2012-02-27 | -$19.71M 10-K · filed 2011-02-23 | ||||
| 2009-09-26 | -$5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | -$6.25M 10-Q · filed 2010-11-04 | ||||||
| 2009-06-27 | -$1.01M 10-Q · filed 2010-08-03 | |||||||
| 2008-12-27 | -$19.63M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |